Daridorexant FDA Approval Status
FDA Approved: No
Generic name: daridorexant
Company: Idorsia Ltd.
Treatment for: Insomnia
Daridorexant is a dual orexin receptor antagonist (DORA) in development for the treatment of insomnia.
Development Timeline for daridorexant
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.